Published in Eur J Pharmacol on March 01, 1969
Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther (2008) 1.44
Effects of drugs acting on cerebral 5-hydroxytryptamine mechanisms on dopamine-dependent turning behaviour in mice. Br J Pharmacol (1976) 1.34
Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines. Br J Pharmacol (1977) 1.10
Effects of specific inhibitors of 5-hydroxytryptamine uptake on thermoregulation in rats. J Physiol (1978) 1.03
Effects of nomifensine in vitro on uptake of 5-hydroxytryptamine and dopamine into human platelets. Br J Clin Pharmacol (1977) 0.95
The binding of some antidepressant drugs to brain muscarinic acetylcholine receptors. Br J Pharmacol (1980) 0.95
On the transmitter function of 5-hydroxytryptamine at excitatory and inhibitory monosynaptic junctions. J Physiol (1974) 0.94
Drug screening to identify suppressors of GFAP expression. Hum Mol Genet (2010) 0.92
Neuropharmacological agents modifying endotoxin-induced changes in mice. J R Soc Med (1980) 0.92
Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets. Br J Pharmacol (1975) 0.91
Serotonin-kynurenine hypothesis of depression: historical overview and recent developments. Curr Drug Targets (2013) 0.90
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors. Neuropsychiatr Dis Treat (2010) 0.90
Release of transmitters into the perfused third cerebral ventrical of the cat. J Physiol (1973) 0.88
Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine. Br J Clin Pharmacol (1983) 0.87
Structure-activity relations for the inhibition of 5-hydroxytryptamine uptake by tricyclic antidepressants into synaptosomes from serotoninergic neurones in rat brain homogenates. Br J Pharmacol (1974) 0.86
On the existence and function of galanin receptor heteromers in the central nervous system. Front Endocrinol (Lausanne) (2012) 0.82
Improvement of the noradrenergic symptom cluster following treatment with milnacipran. Neuropsychiatr Dis Treat (2011) 0.81
Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder. Int J Neuropsychopharmacol (2012) 0.80
In vivo electrochemical measurements of serotonin clearance in rat striatum: effects of neonatal 6-hydroxydopamine-induced serotonin hyperinnervation and serotonin uptake inhibitors. J Neural Transm (Vienna) (1997) 0.79
Evidence for inhibition of the reuptake of 5-hydroxytryptamine and noradrenaline by tetrahydronaphthylamine in rat brain. Br J Pharmacol (1971) 0.79
Further studies on 5-hydroxytryptamine transport in pancreatic islets and isolated beta-cells. Br J Pharmacol (1981) 0.78
Effects of narcotic analgesics on the uptake and release of 5-hydroxytryptamine in rat synaptosomal preparations. Br J Pharmacol (1978) 0.77
The effect of narcotic analgesics on the uptake of 5-hydroxytryptamine and (-)-metaraminol by blood platelets. Br J Pharmacol (1973) 0.77
Chronic treatment with lithium or desipramine alters discharge frequency and norepinephrine responsiveness of cerebellar Purkinje cells. Proc Natl Acad Sci U S A (1979) 0.77
Potentiation by TRH of the effect of antidepressants in the forced-swimming test, involvement of dopaminergic and opioid systems. Br J Pharmacol (1989) 0.76
Tricyclic anti-depressant induced mania. Indian J Psychiatry (1980) 0.76
Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression. Curr Neuropharmacol (2015) 0.75
New horizons in psychopharmacology. Proc R Soc Med (1972) 0.75
Imipramine normalizes naturally-occurring and drug-induced differences in the exploratory activity of rats. Br J Pharmacol (1980) 0.75
Traditional Chinese medicine and Western psychopharmacology: building bridges. Phytother Res (2013) 0.75
Proceedings: The effects of depleting brain amines on the behavioural actions of gamma-hydroxybutyric acid. Br J Pharmacol (1974) 0.75
Plasma levels of clomipramine and its N-desmethyl metabolite following oral administration of clomipramine in man [proceedings]. Br J Pharmacol (1976) 0.75
Central neurotransmitter function and its behavioral correlates in man. Environ Health Perspect (1978) 0.75
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression. Sci Rep (2016) 0.75
Effects of benzoctamine and chlordiazepoxide on turnover and uptake of 5-hydroxytryptamine in the brain. Br J Pharmacol (1974) 0.75
Effects of testosterone and ethinyloestradiol on the synthesis and uptake of noradrenaline and 5-hydroxytryptamine in rat hindbrain: evidence for a presynaptic regulation of monoamine monoamine synthesis? [proceedings]. Br J Pharmacol (1977) 0.75
Effects of halothane on transport of 5-hydroxytryptamine by platelet membranes. Biochem J (1986) 0.75
Platelet uptake of [14C]-5-hydroxytryptamine in "emotional" and "non-emotional" rats [proceedings]. Br J Pharmacol (1976) 0.75
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature (1998) 6.27
A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med (1995) 4.71
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A (1998) 4.14
Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J Pharm Pharmacol (1973) 3.54
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol (1970) 3.54
The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med (1997) 3.49
A prospective randomised trial of internal fixation versus arthroplasty for displaced fractures of the neck of the femur. Functional outcome for 450 patients at two years. J Bone Joint Surg Br (2002) 3.40
Peptidergic neurones. Nature (1980) 3.36
Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand (1982) 3.25
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci U S A (2000) 3.04
The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci U S A (1998) 2.91
Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res (1975) 2.72
Immunohistochemical studies using antibodies to leucine-enkephalin: initial observations on the nervous system of the rat. Neuroscience (1976) 2.56
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36
Substance p: localization in the central nervous system and in some primary sensory neurons. Science (1975) 2.33
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost (2006) 2.32
Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol (1969) 2.26
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci (1997) 2.23
The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm Gen Sect (1993) 2.20
Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry (1992) 2.15
Cellular localization of monoamines in the area postrema of certain mammals. J Comp Neurol (1965) 2.13
Functional role of the nigro-neostriatal dopamine neurons. Acta Pharmacol Toxicol (Copenh) (1966) 2.13
Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P. Proc Natl Acad Sci U S A (1977) 2.11
Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol (1967) 2.08
Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res (1984) 2.05
The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment Pharmacol Ther (2013) 2.01
Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience (1978) 2.01
Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. Proc Natl Acad Sci U S A (1980) 2.00
Distribution of substance P-like immunoreactivity in the central nervous system of the rat--I. Cell bodies and nerve terminals. Neuroscience (1978) 1.99
Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol (1985) 1.97
Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A (1982) 1.95
Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat. Neuroscience (1976) 1.92
Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease. Trends Neurosci (1990) 1.91
High nitric oxide production in human paranasal sinuses. Nat Med (1995) 1.90
Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol (1998) 1.87
Climate change and the integrity of science. Science (2010) 1.80
Flare and itch induced by substance P in human skin. J Invest Dermatol (1978) 1.72
Localization of monoamines in the lower brain stem. Experientia (1964) 1.72
Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacologia (1966) 1.71
High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett (1983) 1.68
Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocr Rev (1987) 1.68
Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience (1978) 1.67
A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett (1984) 1.63
Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc Natl Acad Sci U S A (1986) 1.61
Modification of sympathetic function. Pharmacological depletion of catecholamine stores. Pharmacol Rev (1966) 1.56
On the occurrence of substance P-containing fibers in sympathetic ganglia: immunohistochemical evidence. Brain Res (1977) 1.55
Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol Sci (1999) 1.54
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci U S A (2000) 1.53
Movement patterns of the C-stem femoral component: an RSA study of 33 primary total hip arthroplasties followed for two years. J Bone Joint Surg Br (2005) 1.53
Expression of the vesicular glutamate transporters-1 and -2 in adult mouse dorsal root ganglia and spinal cord and their regulation by nerve injury. Neuroscience (2007) 1.51
Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides (1984) 1.51
Intercellular communication in the brain: wiring versus volume transmission. Neuroscience (1995) 1.50
Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia. Am J Med (1993) 1.50
Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta Physiol Scand (1967) 1.49
Calcitonin gene-related peptide, a peptide present in spinal cord motoneurons, increases the number of acetylcholine receptors in primary cultures of chick embryo myotubes. Neurosci Lett (1986) 1.49
Pharmacological studies on the hypotensive effects of clonidine. Eur J Pharmacol (1971) 1.49
In vitro studies on central and peripheral monoamine neurons at the ultrastructural level. Z Zellforsch Mikrosk Anat (1968) 1.48
High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J (1992) 1.48
Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res (1969) 1.47
Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol (1986) 1.46
Continuous distal migration and internal rotation of the C-stem prosthesis without any adverse clinical effects: an RSA study of 33 primary total hip arthroplasties followed for up to ten years. Bone Joint J (2014) 1.45
Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol (1998) 1.44
Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci U S A (1997) 1.44
Hypothermic effect of apomorphine in the mouse. J Pharm Pharmacol (1972) 1.43
Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci (1986) 1.43
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry (2000) 1.43
Peptide neurons in the vagus, splanchnic and sciatic nerves. Acta Physiol Scand (1978) 1.42
Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: distribution and release by capsaicin. Peptides (1987) 1.41
Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience (1984) 1.41
Immunohistochemical evidence for the localization of somatostatin--like immunoreactivity in a cell population of the pancreatic islets. Med Biol (1974) 1.40
Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. J Neurosci (1998) 1.40
Adenosine-dopamine interactions in the brain. Neuroscience (1992) 1.39
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A (1991) 1.39
Effect of apomorphine on the GABA turnover in the DA cell group rich area of the mesencephalon. Evidence for the involvement of an inhibitory gabergic feedback control of the ascending DA neurons. Neurosci Lett (1975) 1.38
Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia. Science (1974) 1.38
Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca. Pharmacol Rev (1966) 1.37
Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies. Proc Natl Acad Sci U S A (1987) 1.37
Proximal tubule Na+-K+-ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. Am J Physiol (1988) 1.36
Insect immunity. The primary structure of the antibacterial protein attacin F and its relation to two native attacins from Hyalophora cecropia. EMBO J (1984) 1.35
Oral L-dopa treatment of parkinsonism. Acta Med Scand (1970) 1.35
A quantitative study on the nigro-neostriatal dopamine neuron system in the rat. Acta Physiol Scand (1967) 1.35
Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig. Regul Pept (1985) 1.35
Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines. J Pharm Pharmacol (1969) 1.34
Cellular localization of somatostatin in endocrine-like cells and neurons of the rat with special references to the A1-cells of the pancreatic islets and to the hypothalamus. Acta Endocrinol Suppl (Copenh) (1975) 1.34
Adrenergic and cholinergic nerve terminals in skeletal muscle vessels. Acta Physiol Scand (1970) 1.34
The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacology (1971) 1.33
Ammonia synthesis from first-principles calculations. Science (2005) 1.33
Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci (1970) 1.33